Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial

Angiology

Volumn 58, Issue 4, 2007, Pages 450-457

  Baker, Joshua F ^a   Schumacher, H Ralph ^a,b   Krishnan, Eswar ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ADULT; AGE; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GOUT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RISK; SMOKING; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; SMOKING; URIC ACID;

EID: 34548132096     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707303444     Document Type: Article

References (33)

1. Baker JF, Krishnan E., Chen L.,, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 118: 816-826, 2005.
2. Anker SD, Doehner W., Rauchhaus M.,, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107: 1991-1997, 2003.
3. Bickel C., Rupprecht HJ, Blankenberg S.,, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89: 12-17, 2002.
4. Franse LV, Pahor M., Di Bari M.,, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertension 188: 1149-1154, 2000.
5. Lehto S., Niskanen L., Ronnemaa T.,, et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29: 635-639, 1998.
6. Verdecchia P., Schillaci G., Reboldi G.,, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 36: 1072-1078, 2000.
7. Wang JG, Staessen JA, Fagard RH,, et al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37: 1069-1074, 2001.
8. Alderman MH, Cohen H., Madhavean S.,, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34: 144-150, 1999.
9. Short RA, Johnson RJ, Tuttle KR: Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol 25: 36-44, 2005.
10. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 248: 1465-1477, 1982.
11. Multiple Risk Factor Intervention Trial Group: Statistical design considerations in the NHLI Multiple Risk Factor Intervention Trial. J Chron Dis 30: 261-275, 1977.
12. Hypertension Detection and Follow-up Program Cooperative Research Group: Five-year findings of the Hypertension Detection and Follow-up Program, I: reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242: 2562-2571, 1979.
13. Lipid Research Clinics Program: Manual of Laboratory Operations. Vol 1. Bethesda, MD: National Institutes of Health, Department of Health, Education, and Welfare ; 1974: 75-628.
14. Johnson RJ, Kang DH, Feig D.,, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190, 2003.
15. Mazzali M., Kanellis J., Han L.,, et al. Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282: F991 - F997, 2002.
16. Sanchez-Lozada LG, Tapia E., Avila-Casado C.,, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105 - F1110, 2002.
17. Emmerson B.: Atherosclerosis and urate metabolism. Aust N Z J Med 9: 451-454, 1979.
18. Ginsberg MH, Kozin F., O'Malley M.,, et al. Release of platelet constituents by monosodium urate crystals. J Clin Invest 60: 999-1007, 1977.
19. Newland H.: Hyperuricemia in coronary, cerebral and peripheral arterial disease: an explanation. Med Hypotheses 1: 152-155, 1975.
20. Kuwano K., Ikeda H., Oda T.,, et al. Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis. Am J Physiol 270 ( 6, pt 2):H1993-H1999, 1996.
21. Visy JM, Le Coz P., Chadefaux B.,, et al. Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology 41: 1313-1315, 1991.
22. Corry DB, Tuck ML: Uric acid and the vasculature. Curr Hypertens Rep 2006 ; 8: 116-119.
23. Iribarren C., Folsom AE, Eckfeldt JH,, et al. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study: Atherosclerosis Risk in Communities. Stroke 29: 635-639, 1999.
24. Leyva F., Anker S., Swan JW,, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 18: 858-865, 1997.
25. Vasquez-Vivar J., Santos AM, Junqueira VB,, et al. Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid-derived free radicals. Biochem J 314 (pt 3):869-876, 1996.
26. Rao GN, Corson MA, Berk BC: Uric acid stimulates vascular smooth muscle proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266: 8604-8608, 1991.
27. Tapp RJ, Shaw JE, de Courten MP,, et al. Foot complications in type 2 diabetes: an Australian population-based study. Diabet Med 20: 105-113, 2003.
28. Tseng CH: Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabet Med 21: 724-729, 2004.
29. Hink HU, Santanam N., Dikalov S.,, et al. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 22: 1402-1408, 2002.
30. Nieto FJ, Iribarren C., Gross MD,, et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148: 131-139, 2000.
31. Langlois M., De Bacquer D., Duprez D.,, et al. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis 168: 163-168, 2003.
32. Weir CJ, Muir SW, Walters MR,, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34: 1951-1957, 2003.
33. Tsuchiya M., Asada A., Kasahara E.,, et al. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 105: 1155-1157, 2002.